Liu Zi Qin - Net Worth and Insider Trading
Liu Zi Qin Net Worth
The estimated net worth of Liu Zi Qin is at least $4 Million dollars as of 2025-07-22. Liu Zi Qin is the senior management of China Resources Double-Crane Pharmaceutical Co Ltd and owns about 184,500 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) stock worth over $4 Million. Details can be seen in Liu Zi Qin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Liu Zi Qin has not made any transactions after 2022-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Liu Zi Qin
Liu Zi Qin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Liu Zi Qin owns 1 companies in total, including China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) .
Click here to see the complete history of Liu Zi Qin’s form 4 insider trades.
Insider Ownership Summary of Liu Zi Qin
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2022-12-19 | senior management |
Liu Zi Qin Latest Holdings Summary
Liu Zi Qin currently owns a total of 1 stock. Liu Zi Qin owns 184,500 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) as of December 19, 2022, with a value of $4 Million.
Latest Holdings of Liu Zi Qin
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2022-12-19 | 184,500 | 19.46 | 3,590,370 |
Holding Weightings of Liu Zi Qin
Liu Zi Qin Form 4 Trading Tracker
According to the SEC Form 4 filings, Liu Zi Qin has made a total of 3 transactions in China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in China Resources Double-Crane Pharmaceutical Co Ltd is the acquisition of 5,000 shares on December 19, 2022, which cost Liu Zi Qin around $116,940.
Insider Trading History of Liu Zi Qin
- 1
Liu Zi Qin Trading Performance
GuruFocus tracks the stock performance after each of Liu Zi Qin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Liu Zi Qin is -25.12%. GuruFocus also compares Liu Zi Qin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Liu Zi Qin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Liu Zi Qin's insider trading performs compared to the benchmark.
Performance of Liu Zi Qin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -21.01 | | | | | |
| Relative Return to S&P 500(%) | -23.98 | | | | | |
Liu Zi Qin Ownership Network
Ownership Network List of Liu Zi Qin
Ownership Network Relation of Liu Zi Qin
Liu Zi Qin Owned Company Details
What does China Resources Double-Crane Pharmaceutical Co Ltd do?
Who are the key executives at China Resources Double-Crane Pharmaceutical Co Ltd?
Liu Zi Qin is the senior management of China Resources Double-Crane Pharmaceutical Co Ltd. Other key executives at China Resources Double-Crane Pharmaceutical Co Ltd include senior management han shuo , senior management Fan Yan Xi , and Directors & senior managers Lu Wen Chao .
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062)'s detailed insider trading history can be found in Insider Trading Tracker table.
China Resources Double-Crane Pharmaceutical Co Ltd Insider Transactions
Liu Zi Qin Mailing Address
Above is the net worth, insider trading, and ownership report for Liu Zi Qin. Currently GuruFocus does not have mailing address information for Liu Zi Qin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
